Zoetis Inc. (NYSE:ZTS) Given Consensus Rating of “Moderate Buy” by Brokerages

Zoetis Inc. (NYSE:ZTSGet Rating) has earned an average recommendation of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $215.17.

ZTS has been the subject of several research reports. The Goldman Sachs Group lowered their price target on shares of Zoetis from $207.00 to $180.00 and set a “buy” rating for the company in a research report on Friday, November 4th. William Blair reaffirmed an “outperform” rating on shares of Zoetis in a research report on Thursday, November 3rd. Morgan Stanley lowered their price target on shares of Zoetis from $264.00 to $248.00 and set an “overweight” rating for the company in a research report on Tuesday, November 15th. StockNews.com initiated coverage on shares of Zoetis in a research report on Wednesday, October 12th. They issued a “buy” rating for the company. Finally, JPMorgan Chase & Co. lowered their price target on shares of Zoetis from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Monday, October 17th.

Institutional Investors Weigh In On Zoetis

Hedge funds and other institutional investors have recently bought and sold shares of the company. Norway Savings Bank increased its stake in Zoetis by 1.8% during the 2nd quarter. Norway Savings Bank now owns 3,304 shares of the company’s stock valued at $568,000 after purchasing an additional 60 shares in the last quarter. Trail Ridge Investment Advisors LLC increased its stake in Zoetis by 0.9% during the 2nd quarter. Trail Ridge Investment Advisors LLC now owns 6,414 shares of the company’s stock valued at $1,103,000 after purchasing an additional 60 shares in the last quarter. Kistler Tiffany Companies LLC increased its stake in Zoetis by 1.6% during the 2nd quarter. Kistler Tiffany Companies LLC now owns 4,045 shares of the company’s stock valued at $695,000 after purchasing an additional 64 shares in the last quarter. Bristlecone Advisors LLC increased its stake in Zoetis by 0.4% during the 2nd quarter. Bristlecone Advisors LLC now owns 17,837 shares of the company’s stock valued at $3,066,000 after purchasing an additional 65 shares in the last quarter. Finally, TrueWealth Advisors LLC increased its stake in Zoetis by 5.4% during the 2nd quarter. TrueWealth Advisors LLC now owns 1,310 shares of the company’s stock valued at $225,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 90.23% of the company’s stock.

Zoetis Price Performance

Zoetis stock opened at $161.95 on Friday. The stock has a market cap of $75.48 billion, a price-to-earnings ratio of 36.97, a price-to-earnings-growth ratio of 2.77 and a beta of 0.73. The company has a debt-to-equity ratio of 1.12, a current ratio of 2.27 and a quick ratio of 1.48. Zoetis has a 1 year low of $124.15 and a 1 year high of $206.25. The firm has a 50-day moving average of $150.42 and a two-hundred day moving average of $157.15.

Zoetis (NYSE:ZTSGet Rating) last released its quarterly earnings data on Thursday, November 3rd. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.24 by ($0.03). The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $2.08 billion. Zoetis had a net margin of 25.82% and a return on equity of 48.41%. Zoetis’s quarterly revenue was up .6% on a year-over-year basis. During the same period last year, the firm earned $1.25 earnings per share. On average, research analysts forecast that Zoetis will post 4.87 earnings per share for the current year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 1st. Investors of record on Friday, January 20th will be given a dividend of $0.375 per share. This is a boost from Zoetis’s previous quarterly dividend of $0.33. The ex-dividend date is Thursday, January 19th. This represents a $1.50 dividend on an annualized basis and a yield of 0.93%. Zoetis’s dividend payout ratio is presently 29.68%.

About Zoetis

(Get Rating)

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

See Also

Analyst Recommendations for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.